142 related articles for article (PubMed ID: 16904309)
21. Detection of autoantibodies against cyclophilin A and triosephosphate isomerase in sera from breast cancer patients by proteomic analysis.
Tamesa MS; Kuramitsu Y; Fujimoto M; Maeda N; Nagashima Y; Tanaka T; Yamamoto S; Oka M; Nakamura K
Electrophoresis; 2009 Jun; 30(12):2168-81. PubMed ID: 19582718
[TBL] [Abstract][Full Text] [Related]
22. Humoral immune response to p16, a cyclin-dependent kinase inhibitor in human malignancies.
Looi K; Megliorino R; Shi FD; Peng XX; Chen Y; Zhang JY
Oncol Rep; 2006 Nov; 16(5):1105-10. PubMed ID: 17016600
[TBL] [Abstract][Full Text] [Related]
23. Photochemical attachment of biomolecules onto fibre-optics for construction of a chemiluminescent immunosensor.
Leshem B; Sarfati G; Novoa A; Breslav I; Marks RS
Luminescence; 2004; 19(2):69-77. PubMed ID: 15098206
[TBL] [Abstract][Full Text] [Related]
24. A mesofluidic multiplex immunosensor for detection of circulating cytokeratin-positive cells in the blood of breast cancer patients.
Breton F; Bennetau B; Lidereau R; Thomas L; Regnier G; Ehrhart JC; Tauc P; Tran PL
Biomed Microdevices; 2011 Feb; 13(1):1-9. PubMed ID: 20814745
[TBL] [Abstract][Full Text] [Related]
25. Native human autoantibodies targeting GIPC1 identify differential expression in malignant tumors of the breast and ovary.
Yavelsky V; Rohkin S; Shaco-Levy R; Tzikinovsky A; Amir T; Kohn H; Delgado B; Rabinovich A; Piura B; Chan G; Kalantarov G; Trakht I; Lobel L
BMC Cancer; 2008 Aug; 8():247. PubMed ID: 18721484
[TBL] [Abstract][Full Text] [Related]
26. Autoantibody to tumor antigen, alpha 2-HS glycoprotein: a novel biomarker of breast cancer screening and diagnosis.
Yi JK; Chang JW; Han W; Lee JW; Ko E; Kim DH; Bae JY; Yu J; Lee C; Yu MH; Noh DY
Cancer Epidemiol Biomarkers Prev; 2009 May; 18(5):1357-64. PubMed ID: 19423516
[TBL] [Abstract][Full Text] [Related]
27. Application of protein microarrays for multiplexed detection of antibodies to tumor antigens in breast cancer.
Anderson KS; Ramachandran N; Wong J; Raphael JV; Hainsworth E; Demirkan G; Cramer D; Aronzon D; Hodi FS; Harris L; Logvinenko T; LaBaer J
J Proteome Res; 2008 Apr; 7(4):1490-9. PubMed ID: 18311903
[TBL] [Abstract][Full Text] [Related]
28. A new immunosensor for breast cancer cell detection using antibody-coated long alkylsilane self-assembled monolayers in a parallel plate flow chamber.
Ehrhart JC; Bennetau B; Renaud L; Madrange JP; Thomas L; Morisot J; Brosseau A; Allano S; Tauc P; Tran PL
Biosens Bioelectron; 2008 Nov; 24(3):467-74. PubMed ID: 18547800
[TBL] [Abstract][Full Text] [Related]
29. [Autoantibodies to steroid-producing ovarian cells in cancer patients].
Bershteĭn LM; Poroshina TE; Vasil'ev DA; Orlova AV
Vopr Onkol; 2008; 54(5):602-5. PubMed ID: 19069474
[TBL] [Abstract][Full Text] [Related]
30. Immunophenotyping and metastatic localization of breast cancer.
Gioanni JC; Mazeau C; Zanghellini E; Hecht F; Gugenheim J; Crafa F; Granon C; Namer M; Ettore F; Schneider M
Cancer Res; 1994 Oct; 54(20):5464-6. PubMed ID: 7923180
[TBL] [Abstract][Full Text] [Related]
31. The association of RCAS1 serum concentration with the reversibility or irreversibility of the process of immune cytotoxic activity restriction during normal menstrual cycle, cancer relapse, and surgical treatment for various types of squamous cell carcinomas and adenocarcinomas.
Dutsch-Wicherek M; Wicherek L
Am J Reprod Immunol; 2008 Mar; 59(3):266-75. PubMed ID: 18275520
[TBL] [Abstract][Full Text] [Related]
32. Development of a chemiluminescent optical fiber immunosensor to detect Streptococcus pneumoniae antipolysaccharide antibodies.
Marks RS; Margalit A; Bychenko A; Bassis E; Porat N; Dagan R
Appl Biochem Biotechnol; 2000; 89(2-3):117-26. PubMed ID: 11209456
[TBL] [Abstract][Full Text] [Related]
33. Anti-Ri-associated paraneoplastic cerebellar degeneration and breast cancer: an autopsy case study.
Brieva-Ruíz L; Diaz-Hurtado M; Matias-Guiu X; Márquez-Medina D; Tarragona J; Graus F
Clin Neurol Neurosurg; 2008 Dec; 110(10):1044-6. PubMed ID: 18701208
[TBL] [Abstract][Full Text] [Related]
34. Survival of ovarian cancer patients overexpressing the tumour antigen p53 is diminished in case of MHC class I down-regulation.
Leffers N; Lambeck AJ; de Graeff P; Bijlsma AY; Daemen T; van der Zee AG; Nijman HW
Gynecol Oncol; 2008 Sep; 110(3):365-73. PubMed ID: 18571704
[TBL] [Abstract][Full Text] [Related]
35. Detection of protein A produced by Staphylococcus aureus with a fiber-optic-based biosensor.
Chang YH; Chang TC; Kao EF; Chou C
Biosci Biotechnol Biochem; 1996 Oct; 60(10):1571-4. PubMed ID: 8987653
[TBL] [Abstract][Full Text] [Related]
36. Sperm-associated antigen 9, a novel biomarker for early detection of breast cancer.
Kanojia D; Garg M; Gupta S; Gupta A; Suri A
Cancer Epidemiol Biomarkers Prev; 2009 Feb; 18(2):630-9. PubMed ID: 19190149
[TBL] [Abstract][Full Text] [Related]
37. Oxidized LDL, serum oxidizability and serum lipid levels in patients with breast or ovarian cancer.
Delimaris I; Faviou E; Antonakos G; Stathopoulou E; Zachari A; Dionyssiou-Asteriou A
Clin Biochem; 2007 Oct; 40(15):1129-34. PubMed ID: 17673194
[TBL] [Abstract][Full Text] [Related]
38. The "reverse capture" autoantibody microarray : an innovative approach to profiling the autoantibody response to tissue-derived native antigens.
Ehrlich JR; Tang L; Caiazzo RJ; Cramer DW; Ng SK; Ng SW; Liu BC
Methods Mol Biol; 2008; 441():175-92. PubMed ID: 18370319
[TBL] [Abstract][Full Text] [Related]
39. Electrochemical immunosensors in breast and ovarian cancer.
Diaconu I; Cristea C; Hârceagă V; Marrazza G; Berindan-Neagoe I; Săndulescu R
Clin Chim Acta; 2013 Oct; 425():128-38. PubMed ID: 23933123
[TBL] [Abstract][Full Text] [Related]
40. Humoral immune responses to MUC1 in women with a BRCA1 or BRCA2 mutation.
Hermsen BB; Verheijen RH; Menko FH; Gille JJ; van Uffelen K; Blankenstein MA; Meijer S; van Diest PJ; Kenemans P; von Mensdorff-Pouilly S
Eur J Cancer; 2007 Jul; 43(10):1556-63. PubMed ID: 17532207
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
